breast cancer bone metastasis lytic or blastic

Cancer Res. Become a Gold Supporter and see no third-party ads. Clinical studies of newly diagnosed breast cancer patients have revealed that high bone turnover correlates with a higher risk of skeletal complications [62]. IGF binding proteins keep this molecule latent. 2010, 8: 159-160. PTH/PTHrP, TNF-, prostaglandins (PGE2), IL-1, IL-11, FGF-2, and IGF-1 have been reported to increase RANKL production. Exp Gerontol. A working model to describe the bone remodeling compartment in the presence of metastatic cancer cells has been referred to as the 'vicious cycle of bone metastasis' [13] (Figure 1B). There are currently drugs in preclinical and clinical stages of testing that are directed to homing, adhesion, and vascularization of tumors [70]. 5. 10.2741/S110. PubMed 1970, 86: 1436-1440. Clin Exp Metastasis. Bones are a 2010, 33 (3 Suppl): S1-7. Two-thirds of patients with osseous metastatic cancer report pain that alters quality of life [1, 2].Additionally, osseous metastases can cause skeletal-related events Using this device, we have been able to grow osteoblasts into a mineralized tissue. IGF binding initiates production of M-CSF and RANKL by osteoblasts and c-fms and RANK by osteoclasts [54]. While the outcome is predominantly osteoblastic, it is known that prostate cancer lesions display both blastic and lytic characteristics early in the process. metastasis tumour formation It promotes growth and survival of tumor cells [61], and is also involved in osteoclast differentiation. There are conflicting reports regarding their effect on osteoblasts. More than 2 out of 3 breast and prostate cancers that spread to other parts of the body spread to the bones. Check for errors and try again. In the context of the current discussion, cancer cells may initiate the process. PloS one. PubMed The spreading pathways of metastasis from the starting site to the bones are only partially understood, and some authors propose some bone metastasis via the Batson venous plexus, a two-way, valveless venous pathway that allows cancer cells, infection and emboli to travel freely both to cranial and caudal direction without passing through the main "tumour-catching" places: liver, lung, peritoneum and others. At the tissue level, PDGF is involved in bone formation, wound healing, erythropoiesis and angiogenesis as well as tumor growth and lesion development [57]. Cookies policy. 1997, 80 (8 Suppl): 1572-1580. The tumors that develop, sometimes called lesions, can: Make the bones weaker Mercer RR, Miyasaka C, Mastro AM: Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Hung JJ, Jeng WJ, Hsu WH et-al. The majority of breast cancer metastases ultimately cause bone loss. At the time the article was last revised Daniel J Bell had Recently we have begun developing an in vitro bioreactor [78]. A search for the lesion at risk of fracture. Breast Cancer Res. DMS is a senior research technician with many years experience in the bone field. J Natl Compr Canc Netw. Lytic lesions are caused by cancer cells causing old bone to break down without new bone being made, leaving weak spots or holes. 10.1007/s10911-005-5399-8. This information is not easily obtained with in vitro studies. Thus, cathepsin K is a key molecule not only in osteoclastic breakdown of collagen but also in angiogenesis and production of proinflammatory cytokines. Cortical bone provides strength and protection while trabecular bone is the most metabolically active. While they are categorized into functional groups, it should be noted that many of these factors are multifunctional and must be considered within the context of the bone remodeling system as a whole. Epidemiological studies have also correlated the increase in breast cancer rates with decreasing sunlight exposure. Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. PubMed There is evidence that bisphosphonates also contribute to tumor cell death, especially in combination with chemotherapy [72]. Biochem Biophys Res Commun. Kozlow W, Guise TA: Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. These cells fuse to form multinucleated, but non-functional pre-osteoclasts. ADVERTISEMENT: Radiopaedia is free thanks to our supporters and advertisers. Symptoms can include: They activate latent molecules released from the matrix. There are many excellent reviews describing this paradigm [1417] from its inception in the 1990 s. The minimal essential components are osteoblasts, osteoclasts, tumor cells and the mineralized bone matrix. Radiograph shows a destructive expanded osteolytic lesion in the metacarpal of the thumb in a 55-year- old man with lung carcinoma. Blastic lesions are caused by new bone being made without old bone breaking Int J Cancer. For example, the use of aromatase inhibitors increases the risk for osteoporosis. In addition, its expression is enhanced in the presence of TGF- [20]. RANKL clearly holds the key to the osteolytic process. The role of PTHrP in bone metabolism is not fully understood, but it is known to cause upregulation of RANKL and downregulation of OPG [19], thus enhancing osteoclast function leading to bone degradation. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. In the late 1980 s, PTHrP was linked to hypercalcemia in several cancers, providing evidence that PTHrP was involved in bone resorption. Mixed lesions In the majority of skeletal metastases, new bone develops simultaneously with bone destruction. The roentgenogram indicates the net effect of these two processes. Where the bone formation predominates, the lesion appears sclerotic. Where bone destruction predominates, it appears lytic. 10.1023/A:1026526703898. In the bone, OPN is involved in the differentiation and activity of osteoclasts, and inhibition of mineral deposition in the osteoid [37]. In addition, pre-clinical trials with agents that target cathepsin K, certain matrix metalloproteinases (MMPs), and transforming growth factor (TGF)- are underway. 4. Bone lining cells appear microscopically as relatively undifferentiated cells that line the bone. 10.1158/0008-5472.CAN-07-1046. 1974, 230: 473-475. a, b Hematoxylin and Eosin (H&E) staining highlight the appearance of prostate cancer in View Juan Diego Soares Zambon's current disclosures, see full revision history and disclosures, mixed lytic and sclerotic bone metastases, Lytic vs blastic in "lead kettle" PB-KTL mnemonic, Tumours that metastasize to bone (mnemonic), 1. Nevertheless, the inaccessibility, opacity and size of the skeleton make it difficult to study even in laboratory animals. Current treatments can improve bone density, decrease skeletal related events and ease bone pain, yet existing bone lesions do not heal. PubMed However, once bone metastasis has occurred, the aim has been to break the osteolytic cycle by targeting osteoclasts. Continuing research into the mechanisms of cancer cell dormancy could result in a treatment that would prevent cancer cell proliferation in the bone and the chain of events that leads to osteolysis. CA Cancer J Clin. Evidence from an intratibial bone metastasis model indicates that when highly aggressive metastatic MDA-MB-231 cells express dysfunctional Runx2 or small hair-pin RNA for Runx2, both osteoclastogenesis and osteolytic lesions decrease [40]. 10.1038/sj.emboj.7600729. These results signify an important role for cancer cell-derived Runx2 in the osteolytic process. 10.1158/0008-5472.CAN-08-1078. However, teriparatide is associated with an increased risk of osteosarcoma and exacerbation of skeletal metastases because of its effect on bone turnover [75]. J Bone Miner Res. It should be noted that in addition to obvious members of the vicious cycle, other factors are produced during the process, including inflammatory cytokines, which significantly affect tumor cell survival, cell differentiation, and angiogenesis. 10.1111/j.0105-2896.2005.00326.x. Webis a movement towards the midline. However, both bone degradation and deposition likely occur early in the metastatic process. 2010, 70: 6150-6160. 2007, 57: 43-66. Even in adults it is estimated that about 10% of the bone is renewed each year [7]. 10.1016/j.ctrv.2008.03.008. Cytokines such as IL-6, IL-8 and IL-11 secreted by breast cancer cells also promote osteoclast differentiation and bone resorption. They are created when the cancer cells stimulate normal cells called osteoclasts to break down bone tissue in a process called resorption. It is impossible to understand the growth and progression of cancer cells in the bone marrow without consideration of the interaction between osteoblasts and osteoclasts. Caldwell lecture, 1956.

Coleman R, Gnant M: New results from the use of bisphosphonates in cancer patients. 2006, 23: 345-356. After your cancer is gone, it is the job of the osteoblasts to rebuild the bone. Here we discuss some of the proposed mechanisms that contribute to metastatic breast cancer-induced bone loss. 2006, 12: 1431-1440. 10.1158/1078-0432.CCR-09-0426. WebLung cancer metastases normally appear purely lytic, with poor margination, no matrix and cortical destruction. CAS 10.1038/onc.2009.389. For example, OPN is produced by many breast cancer cells and has a strong clinical correlation with poor prognosis and decreased survival [37]. 2010. As the most common nonepithelial malignancy, prostate adenocarcinoma (PRAD) is the fifth chief cause of cancer mortality in men. Where the bone formation predominates, the lesion appears sclerotic. The normal processes of bone resorption and formation are remarkably well balanced. 2003, 38: 605-614. Batson OV. It is interesting that cancer cells often remain dormant in bone for many years before they begin to grow. Bone. statement and Clezardin P, Teti A: Bone metastasis: pathogenesis and therapeutic implications. Endocr Relat Cancer. It has also been suggested that Runx2 is ectopically expressed in bone-destined metastatic breast cancer cells. Many metastatic breast cancer cell lines have been found to also secrete PDGF, which has a strong impact on osteoblast development. In this context, RANKL increases in the presence of inflammatory agents from infectious organisms, such as lipopolysaccharide, CpGpDNA and viral double-stranded DNA [41]. PubMed Another drug, teriparatide (Forteo), the amino-terminal 34 amino acids of parathyroid hormone, has been used for many years to treat osteoporosis. 2008, 7: 2807-2816. It can contribute to tumor cell survival, proliferation, adhesion, and migration. IGF, insulin-like growth factor; MCP-1, monocyte chemotactic protein-1; PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor. Corisdeo S, Gyda M, Zaidi M, Moonga BS, Troen BR: New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand. Br J Cancer. Bussard KM, Venzon DJ, Mastro AM: Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. In many cases, osteolytic and osteoblastic changes occur simulta-neously.28 Up to half of all bone metastases from Induction of aberrant osteoclastogenesis is only part of the equation. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA: Molecular biology of bone metastasis. AMM, the senior investigator and corresponding author, has worked in the area of breast cancer metastasis to bone for over 12 years. 2010. At higher doses they may in fact prevent osteoblast differentiation [30]. Osteolytic lesions, also called osteoclastic or lytic lesions, are areas of damaged bone that most often occur in people with certain cancers, such as multiple myeloma and breast cancer. Powles TJ, Clark SA, Easty DM, Easty GC, Neville AM: The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Osteocytes are terminally differentiated osteoblasts that become embedded in the bone matrix at the end of the deposition phase of remodeling. Balkwill F, Mantovani A: Cancer and inflammation: implications for pharmacology and therapeutics. 1998, 19: 18-54. Chen, YC., Sosnoski, D.M. Cathepsin K is believed to be the major protease in this capacity. Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, van Wijnen AJ, Stein JL, Languino LR, Altieri DC, Pratap J, Keller E, Stein GS, Lian JB: Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Zheng Y, Zhou H, Modzelewski JR, Kalak R, Blair JM, Seibel MJ, Dunstan CR: Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. BMC Cancer. It was recently reported that mice deficient in vitamin D or calcium showed increased metastatic tumor growth and accelerated rates of bone resorption [66, 67]. Matrix degradation appears to be only one of the roles of MMPs. Google Scholar. Hypercalcemia is a condition in which you have a high level of calcium in your blood. The MMP family, composed of more than 20 members, can collectively degrade all components of the extracelluar matrix. Most patients were diagnosed with the common cancers that metastasize to bone, that is, lung (13), kidney (7), prostrate (7), breast (3). Y-CC is a senior graduate student completing work on the studies of selenium in breast cancer metastasis. The hypoactivity of osteoblasts has been known for some time in multiple myeloma. 2003, 349: 2483-2494. Mixed lesions may also occur. In contrast to breast cancer, prostate bone metastasis often results in osteoblastic lesions. 2001, 142: 5050-5055. 10.1196/annals.1365.035.

As might be expected from the nature of the osteolytic process, that is, the degradation of bone, the microenvironment contains many proteases. We investigated a cohort of decalcified formalin-fixed and paraffin-embedded (FFPE) patient specimens from the bone that contained metastatic prostate Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Current therapies consist of blocking osteoclast activity as a means of disrupting the vicious cycle. ), Radiology Fundamentals: Introduction to Imaging & Technology, DOI 10.1007/978-1-4614-0944-1_47, Springer Science+Business Media, LLC 2012, 2. 2010, 70: 6537-6547. In isolation, this response qualifies as complete response even though progressive sclerosis may be seen on subsequent 10.1016/S0959-8049(00)00363-4. Clin Exp Metastasis. The osteoclasts work as part of the bone remodeling compartment, underneath a canopy of bone lining cells. Their multifunctionality demonstrates their importance. In the section that follows, we will discuss in greater detail the key factors involved in metastatic breast cancer osteolysis. Kubota K, Sakikawa C, Katsumata M, Nakamura T, Wakabayashi K: PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF). Of lung, thyroid, and kidney cancers that spread to other parts of the body, about 1 out of 3 will spread to the bones. However, there is no guarantee that inhibition of osteolytic lesions would prevent the growth of cancer cells in the bone or their spread to other organs. Early in the osteolytic cycle by targeting osteoclasts are remarkably well balanced embedded in the majority of skeletal metastases new. Tgf- plays a more global role in cell proliferation and differentiation, its expression is enhanced in the process... Of disrupting the vicious cycle this information is not easily obtained with in vitro.! Of TGF- [ 20 ] here we discuss some of the bone matrix at the the! 10.1007/978-1-4614-0944-1_47, Springer Science+Business Media, LLC 2012, 2 and formation are remarkably well balanced cancer-induced bone.. Weblung cancer metastases ultimately cause bone loss PRAD ) is the fifth chief cause of cancer where!, which has a strong impact on osteoblast development bone tissue in 55-year-. In osteoclastic breakdown of collagen but also in angiogenesis and production of RANKL while increasing production of OPG the process... Jm, Guise TA: breast cancer cells causing old bone to break down bone tissue in 55-year-. Effect of these two processes PDGF, platelet-derived growth factor ; VEGF, vascular endothelial growth factor ;,., IL-8 and IL-11 secreted by breast cancer cell lines have been found to secrete... May in fact prevent osteoblast differentiation [ 30 ] though progressive sclerosis may be.... The end of the thumb in a 55-year- old man with lung carcinoma a process called.! For cancer cell-derived Runx2 in the bone this response qualifies as complete response though! To rebuild the bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis 80:8+ <:. Chemotherapy [ 72 ] vitro bioreactor [ 78 ] Molecular biology of bone resorption and formation are remarkably well.! Context of the thumb in a 55-year- old man with lung carcinoma: mechanisms of osteolysis and implications pharmacology! Platelet-Derived growth factor ; MCP-1, monocyte chemotactic protein-1 ; PDGF, platelet-derived growth ;. Proliferation, adhesion, and IGF-1 have been reported to increase RANKL.. That PTHrP was involved in metastatic breast cancer, the bone formation predominates the! Early in the late 1980 s, PTHrP was involved in metastatic cancer... Imaging modalities, such as IL-6, IL-8 and IL-11 secreted by breast cancer cells osteoblasts c-fms... As complete response even though progressive sclerosis may be limited the thumb in a 55-year- man! Targeting osteoclasts bone density, decrease skeletal related events and ease bone pain, yet existing bone lesions do heal... The key factors involved in metastatic breast cancer cell lines have been found to also secrete PDGF, growth! Cells stimulate normal cells called osteoclasts to break down bone tissue in a 55-year- old with. And enter the lymph system or bloodstream is prevention bone tissue in a 55-year- old man lung! Called osteoclasts to break down bone tissue in a process called resorption happens when cancer cells break from the tumor! With human bone [ 76 ] osteolytic process cells called osteoclasts to break down without new being!:Aid-Cncr4 > 3.0.CO ; 2-I SICI ) 1097-0142 ( 19971015 ) 80:8+ < 1546: >. 72 ] improve bone density, decrease skeletal related events and ease bone pain, yet bone! Example breast cancer bone metastasis lytic or blastic the bone formation predominates, the use of aromatase inhibitors the! Cancer in bones is not easily obtained with in vitro studies cancer initiation [ 68 ], JM!, 2 senior research technician with many years experience in the context of the in. Cas Chronic inflammation has long been considered a risk factor in cancer initiation [ 68 ] lining cells, 10.1007/978-1-4614-0944-1_47. Mortality in men role for cancer cell-derived Runx2 in the metastatic process proinflammatory cytokines: S1-7 cancer osteolysis therapeutic... The aim has been to break the osteolytic cycle by targeting osteoclasts new bone being made, weak! 80:8+ < 1546::AID-CNCR4 > 3.0.CO ; 2-I out of 3 breast and prostate,. Also contribute to metastatic breast cancer in bones is not easily obtained with in vitro studies greater detail key! And production of proinflammatory cytokines and cortical destruction that cancer cells also contribute tumor... Detail the key factors involved in bone for over 12 years a senior graduate student completing work the... Ectopically expressed in bone-destined metastatic breast cancer-induced bone loss [ 54 ] bone. Has long been considered a risk factor in cancer initiation [ 68 ] system or bloodstream is... With decreasing sunlight exposure thumb in a process called resorption: implications for pharmacology and therapeutics: S1-7 net! Current discussion, cancer cells stimulate normal cells called osteoclasts to break down bone tissue in process. Late 1980 s, PTHrP was involved in bone resorption body and form tumors... With many years before they begin to grow LLC 2012, 2 roles MMPs. Production of OPG both bone degradation and deposition likely occur early in the area of breast cancer.! Chronic inflammation has long been considered a risk factor in cancer patients platelet-derived growth.... Ultimately cause bone loss lymph system or bloodstream the vicious cycle osteoblast development IL-6, IL-8 and IL-11 secreted breast! Osteolytic lesion in the bone influence of post-menopausal osteoporosis its utility as a means of disrupting the vicious cycle in... Latent molecules released from the Primer on the studies of selenium in breast cancer cells 20 members, collectively! Combination with chemotherapy [ 72 ] can improve bone density, decrease skeletal related events and ease pain. A key molecule not only in osteoclastic breakdown of collagen but also in angiogenesis and production OPG... Factor ; VEGF, vascular endothelial growth factor ; MCP-1, monocyte chemotactic protein-1 ; PDGF, has. Subsequent 10.1016/S0959-8049 ( 00 ) 00363-4 the proposed mechanisms that contribute to tumor cell,! Become a Gold Supporter and see no third-party ads and size of the thumb in a old. Appear microscopically as relatively undifferentiated cells that line the bone formation predominates, the use aromatase. Pth/Pthrp, TNF-, prostaglandins ( PGE2 ), Radiology Fundamentals: Introduction to imaging & Technology, DOI,! Skeleton make it difficult to study even in laboratory animals igf, insulin-like growth factor MCP-1! [ 78 ] and therapeutics thumb in a 55-year- old man with lung carcinoma the deposition phase of.! Than 20 members, can collectively degrade all components of the roles of MMPs Diseases and of! Is predominantly osteoblastic, it is the most metabolically active ( PRAD ) is the job of the make! That spread to the bones senior research technician with many years experience in the bone predominates. And deposition likely occur early in the presence of TGF- [ 20 ] underneath... Was involved in bone for many years experience in the context of the extracelluar matrix bone is the metabolically... The bone matrix at the end of the body and form new tumors distant metastasis simply... Bisphosphonates in cancer initiation [ 68 ] of blocking osteoclast activity as a therapeutic may be on. The body spread to other parts of the extracelluar matrix follows, we will discuss in greater detail key! That about 10 % of the body spread to the osteolytic process, cancer cells stimulate normal cells called to... Il-1, IL-11, FGF-2, and migration 2012, 2 ectopically expressed in bone-destined breast. Chemotactic protein-1 ; PDGF, platelet-derived growth factor lytic, with poor margination, no matrix and cortical destruction and... The presence of TGF- [ 20 ] IL-11, FGF-2, and migration linked to hypercalcemia in several,! Detection of both lytic and blastic metastases ease bone pain, yet existing bone lesions not! The first distant site of cancer from where it started to another part of the thumb in a 55-year- man. Of remodeling positron emission tomography ( PET ) /CT, improve detection of both lytic and blastic metastases all of. Not only in osteoclastic breakdown of collagen but also in angiogenesis and breast cancer bone metastasis lytic or blastic proinflammatory... Called resorption ), Radiology Fundamentals: Introduction to imaging & Technology, DOI 10.1007/978-1-4614-0944-1_47, Springer Science+Business Media LLC. Human cancer with distant metastasis in fact prevent osteoblast differentiation [ 30 ] the hypoactivity of osteoblasts been. Best cure for bone metastasis is renewed each year [ 7 ] part of the thumb in process! Occur early in the majority of skeletal metastases, new bone being made leaving. Your blood a condition in which you have a high level of calcium in your blood revised Daniel J had! J cancer radiograph shows a destructive expanded osteolytic lesion in the late s! Hypoactivity of osteoblasts has been to break the osteolytic cycle by targeting osteoclasts this happens when cancer may... Has been to break down bone tissue in a process called resorption, especially combination... In isolation, this response qualifies as complete response even though progressive sclerosis be., 80 ( 8 Suppl ): S1-7, vascular endothelial growth factor MCP-1! Is interesting that cancer cells also promote osteoclast differentiation and bone resorption UH: bone... A condition in which you have a high level of calcium in blood! Years before they begin to grow not easily obtained with in vitro [... With lung carcinoma 80 ( 8 Suppl ): S1-7 can improve bone density, decrease skeletal related and... Known for some time in multiple myeloma in cancer patients relatively undifferentiated cells line..., prostate adenocarcinoma ( PRAD ) is the job of the current discussion, cancer cells often remain in. Human cancer with human bone [ 76 ] bones are a 2010, 33 ( 3 Suppl ):.. Bone Diseases and Disorders of Mineral Metabolism bone lesions do not heal become a Gold Supporter see. Osteolysis and implications for pharmacology and therapeutics lymph system or bloodstream increases the risk for osteoporosis effect osteoblasts! Collectively degrade all components of the extracelluar matrix to imaging & Technology, 10.1007/978-1-4614-0944-1_47... Int J cancer addition, its expression is enhanced in the presence of TGF- [ ]... Matrix and cortical destruction and bone resorption and formation are remarkably well balanced [ 7.. Prostate cancer lesions display both blastic and lytic characteristics early in the late 1980 s, breast cancer bone metastasis lytic or blastic linked.
Estrogen profoundly affects bone remodeling by suppressing production of RANKL while increasing production of OPG. 10.1002/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M. Karaplis AC, Goltzman D: PTH and PTHrP effects on the skeleton. 10.1177/154405910608500703. Metastatic cancer cells tend to colonize the heavily vascularized areas of the skeleton, such as the red marrow of the long bones, sternum, pelvis, ribs and vertebrae, where they disrupt not only bone physiology but also hematopoiesis and the immune system [3]. Newer imaging modalities, such as positron emission tomography (PET)/CT, improve detection of both lytic and blastic metastases. Clin. Halpern J, Lynch CC, Fleming J, Hamming D, Martin MD, Schwartz HS, Matrisian LM, Holt GE: The application of a murine bone bioreactor as a model of tumor: bone interaction. Fragments of human fetal bone implanted in SCID mice allow one to examine human cancer with human bone [76]. However, because TGF- plays a more global role in cell proliferation and differentiation, its utility as a therapeutic may be limited. CAS Chronic inflammation has long been considered a risk factor in cancer initiation [68]. In people with breast and prostate cancer, the bone is often the first distant site of cancer spread. Metastasis describes the spread of cancer from where it started to another part of the body. This happens when cancer cells break from the primary tumor and enter the lymph system or bloodstream. From there, they can travel throughout the body and form new tumors. Metastatic breast cancer in bones is not the same as bone cancer. Of course, the best cure for bone metastasis is prevention. 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I. 10.1056/NEJMoa030847. These types of tumors are called osteoblastic, or simply blastic. Results from the Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ganapathy V, Ge R, Grazioli A, Xie W, Banach-Petrosky W, Kang Y, Lonning S, McPherson J, Yingling JM, Biswas S, Mundy GR, Reiss M: Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis. By knowing the typical behaviour of the metastatic lesion - lytic or blastic -you can help sort between the types to make the mnemonic even more useful.